Abstract:Innate recognition of invading intracellular pathogens is essential for regulating robust and rapid CD4+ T cell effector function, which is critical for host-mediated immunity. The intracellular apicomplexan parasite, Toxoplasma gondii, is capable of infecting almost any nucleated cell of warm-blooded animals, including humans, and establishing tissue cysts that persist throughout the lifetime of the host. Recognition of T. gondii by TLRs is essential for robust IL-12 and IFN-γ production, two major cytokines involved in host resistance to the parasite. In the murine model of infection, robust IL-12 and IFN-γ production have been largely attributed to T. gondii profilin recognition by the TLR11 and TLR12 heterodimer complex, resulting in Myd88-dependent IL-12 production. However, TLR11 or TLR12 deficiency failed to recapitulate the acute susceptibility to T. gondii infection seen in Myd88-/- mice. T. gondii triggers inflammasome activation in a caspase-1-dependent manner resulting in cytokine release; however, it remains undetermined if parasite-mediated inflammasome activation impacts IFN-γ production and host resistance to the parasite. Using mice which lack different inflammasome components, we observed that the inflammasome played a limited role in host resistance when TLR11 remained functional. Strikingly, in the absence of TLR11, caspase-1 and -11 played a significant role for robust CD4+ TH1-derived IFN-γ responses and host survival. Moreover, we demonstrated that in the absence of TLR11, production of the caspase-1-dependent cytokine IL-18 was sufficient and necessary for CD4+ T cell-derived IFN-γ responses. Mechanistically, we established that T. gondii-mediated activation of the inflammasome and IL-18 were critical to maintain robust CD4+ TH1 IFN-γ responses during parasite infection in the absence of TLR11.It is currently estimated that one third of the world's population is seropositive for the parasite Toxoplasma gondii and this parasite can lead to serious illness and death in immunocompromised patients, and is one of the leading causes of foodborne-related deaths in the United States. Host immunity against the parasite has largely been attributed to recognition of the parasite-derived protein, profilin, by the innate Toll-like receptors (TLRs), TLR11 and TLR12. T. gondii also triggers inflammasome activation in a caspase-1-dependent manner resulting in cytokine release. However, how these innate recognition systems regulate TH1 immunity and host resistance remains largely unknown. Therefore, using genetically modified mice, we investigated TLR11-dependent and -independent host immunity against the parasite. Our research establishes that in the absence of TLR11, inflammasome activation and subsequent production of the inflammasome-dependent molecule, IL-18 are critical for host immunity to the parasite. These data provide novel mechanistic insight into how TLR and inflammasomes cooperate in regulation of TH1 immunity and host protection.

Toxoplasma gondii dense granule protein GRA24 drives MyD88-independent p38 MAPK activation, IL-12 production and induction of protective immunity

Toxoplasma GRA15 and GRA24 are important activators of the host innate immune response in the absence of TLR11

T lymphocyte-dependent IL-10 down-regulates a cytokine storm driven by Toxoplasma gondii GRA24

TLR11-independent inflammasome activation is critical for CD4+ T cell-derived IFN-γ production and host resistance to Toxoplasma gondii

A combination of four Toxoplasma gondii nuclear-targeted effectors protects against interferon gamma-driven human host cell death

Protective efficacy of recombinant Toxoplasma gondii dense granule protein 15 against toxoplasmosis in C57BL/6 mice

Toxoplasma type II effector GRA15 has limited influence in vivo

The IL-12 Response of Primary Human Dendritic Cells and Monocytes to Toxoplasma gondii Is Stimulated by Phagocytosis of Live Parasites Rather Than Host Cell Invasion

Targeted Overexpression of Cyclic AMP-dependent Protein Kinase Subunit in Toxoplasma Gondii Promotes Replication and Virulence in Host Cells.

Host E3 ubiquitin ligase ITCH mediates Toxoplasma gondii effector GRA35-triggered NLRP1 inflammasome activation and cell-autonomous immunity

MyD88 is Crucial for the Development of a Protective CNS Immune Response to Toxoplasma Gondii Infection

The GRA15 Protein from Toxoplasma Gondii Enhances Host Defense Responses by Activating the Interferon Stimulator STING

The role of IFN-γ-mediated host immune responses in monitoring and the elimination of Toxoplasma gondii infection

The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐T. Gondii Immunity and Tumor Immunotherapy

Mechanisms of Human Innate Immune Evasion by Toxoplasma gondii

Toxoplasma gondii glycosylphosphatidylinositols up-regulate major histocompatibility complex (MHC) molecule expression on primary murine macrophages

Dense granule protein 3 of Toxoplasma gondii plays a crucial role in the capability of the tissue cysts of the parasite to persist in the presence of anti-cyst CD8+ T cells during the chronic stage of infection

Transcriptomics analysis of Toxoplasma gondii-infected mouse macrophages reveals coding and noncoding signatures in the presence and absence of MyD88

Natural Killer Cell Intrinsic Toll-Like Receptor MyD88 Signaling Contributes to IL-12-dependent IFN-γ Production by Mice During Infection with Toxoplasma Gondii.

Activation of NF-κB Signaling by the Dense Granule Protein GRA15 of a Newly Isolated Type 1 Toxoplasma Gondii Strain.

Toxoplasma gondii infection induces the expression of the chemokine CXCL16 in macrophages to promote chemoattraction of CXCR6+ cells